Ipsos publishes health report as Ipsos stock sits 15.75 percent below its high

Published on 10/08/2026 at 14:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ipsos stock costs EUR 36.21 on October 8, 2026, versus EUR 35.96. Results are due October 23, and the 52-week high is EUR 42.98.

Makroaufnahme eines Umfragebogens mit Checkbox-Markierungen und Stift — Ipsos SA (ISIN FR0000073298) Makroaufnahme eines Umfragebogens mit angekreuzten Checkbox-Markierungen und einer feinen Stiftspitze, Illustration mit AI erstellt.

Ipsos (ISIN FR0000073298) was trading at EUR 36.21 at Lang & Schwarz on October 8, 2026, 15.75 percent below its 52-week high of EUR 42.98. On October 8, MarketScreener reported Ipsos SA's Health Service Report 2026, giving the market a fresh operational data point ahead of the company's third-quarter results.

Three milestones shape the story

On September 14, 2026, Ipsos said organic revenue growth stood at 1.10 percent by August 31, compared with 0.80 percent at the end of the first half, while organic order-book growth was 1.20 percent. The figures came from Webdisclosure's account of the investor presentation.

Between September 21 and 25, Ipsos continued its share buyback program, including 7,719 shares purchased on September 23, 2026, according to Yahoo Finance. The capital action adds a shareholder-return element to a period in which revenue growth remains positive but modest.

On October 8, the Health Service Report said mental health was identified as one of the biggest health problems by 48 percent of respondents across 32 countries, ahead of cancer at 40 percent, stress at 32 percent and obesity at 25 percent. For Ipsos, the report demonstrates the breadth of its research franchise while also showing that the latest operational growth figures remain the more direct stock-market measure.

What does the health report add?

The report gives Ipsos a timely showcase for its global survey platform, but its commercial relevance depends on converting research activity into stronger organic growth. The comparison between 1.10 percent growth by August 31 and 0.80 percent at the end of the first half points to an improvement of 0.30 percentage points, while the 1.20 percent order-book growth indicates a similar level of measured momentum.

Results date sets the next test

Webdisclosure said Ipsos will present its third-quarter 2026 results on October 23, 2026, at 8:30 a.m. CET. That release should test whether the 1.10 percent organic growth rate and 1.20 percent order-book growth have continued into the reporting period.

Stock remains below EUR 43.00

Ipsos had a market capitalization of EUR 1.5 billion as of October 8, 2026, while its 52-week range was EUR 29.10 to EUR 42.98. At Lang & Schwarz, the stock was trading at EUR 36.21 on October 8, 2026 at 2:02 p.m. CEST, plus 0.70 percent versus the prior close of EUR 35.96 on October 7, 2026.

The further course of trading is shown by the continuously updated real-time quote of Ipsos stock.